Evidence map›Paper›PMID 31652763›Full record

ReviewInternational journal of molecular sciences2019

Citrus Genetic Engineering for Disease Resistance: Past, Present and Future.

Lifang Sun, Nasrullah, Fuzhi Ke, Zhenpeng Nie, Ping Wang, Jianguo Xu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
12.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Innovative strategies for characterizing and managing huanglongbing in citrus.World journal of microbiology & biotechnology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The GRAS Salts of NaFoods (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lifang SunInstitute of Citrus Research, Zhejiang Academy of Agricultural Sciences, Taizhou 318026, China. sun6286855@126.com.ORCID 0000-0002-7788-1569
NasrullahDepartment of Plant Biology and Ecology, College of Life Sciences, Nankai University, Tianjin 300071, China. nasr_pak47@yahoo.com.
Fuzhi KeInstitute of Citrus Research, Zhejiang Academy of Agricultural Sciences, Taizhou 318026, China. kfzcitrus@163.com.
Zhenpeng NieInstitute of Citrus Research, Zhejiang Academy of Agricultural Sciences, Taizhou 318026, China. niezp168@126.com.
Ping WangInstitute of Citrus Research, Zhejiang Academy of Agricultural Sciences, Taizhou 318026, China. iamwangping@163.com.
Jianguo XuInstitute of Citrus Research, Zhejiang Academy of Agricultural Sciences, Taizhou 318026, China. xujggjs@sohu.com.
Citrus Research Institute · CNNankai University · CN

Funding

Jianguo Xu CARS-26; 2016C12904-1
6 · The paper itself

Abstract

Worldwide, citrus is one of the most important fruit crops and is grown in more than 130 countries, predominantly in tropical and subtropical areas. The healthy progress of the citrus industry has been seriously affected by biotic and abiotic stresses. Several diseases, such as canker and huanglongbing, etc., rigorously affect citrus plant growth, fruit quality, and yield. Genetic engineering technologies, such as genetic transformation and genome editing, represent successful and attractive approaches for developing disease-resistant crops. These genetic engineering technologies have been widely used to develop citrus disease-resistant varieties against canker, huanglongbing, and many other fungal and viral diseases. Recently, clustered regularly interspaced short palindromic repeats (CRISPR)-based systems have made genome editing an indispensable genetic manipulation tool that has been applied to many crops, including citrus. The improved CRISPR systems, such as CRISPR/CRISPR-associated protein (Cas)9 and CRISPR/Cpf1 systems, can provide a promising new corridor for generating citrus varieties that are resistant to different pathogens. The advances in biotechnological tools and the complete genome sequence of several citrus species will undoubtedly improve the breeding for citrus disease resistance with a much greater degree of precision. Here, we attempt to summarize the recent successful progress that has been achieved in the effective application of genetic engineering and genome editing technologies to obtain citrus disease-resistant (bacterial, fungal, and virus) crops. Furthermore, we also discuss the opportunities and challenges of genetic engineering and genome editing technologies for citrus disease resistance.

Indexed as

Disease ResistanceCitrusCRISPR-Cas SystemsGene EditingGenetic EngineeringPlant Breedingbreedingcitrusdisease resistancegenetic engineering

Identifiers

PMID31652763
PMCPMC6862092
OpenAlexW2981850085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.